Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sodium Fluoride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 108Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of September 18, 2024
    Enforcement Report - Week of September 18, 2024

    18 Sep 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-18-2024-41403.pdf

    FDA
    18 Sep 2024
    Share Share
    Kaylaan LLC Receives FDA Warning Letter
    Kaylaan LLC Receives FDA Warning Letter

    03 Sep 2024

    // FDA

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kaylaan-llc-681977-08192024

    FDA
    03 Sep 2024
    Share Share
    Enforcement Report - Week of October 25, 2023
    Enforcement Report - Week of October 25, 2023

    25 Oct 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-25-2023-66768.pdf

    FDA
    25 Oct 2023
    Share Share
    Enforcement Report - Week of September 13, 2023
    Enforcement Report - Week of September 13, 2023

    13 Sep 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2023-60327.pdf

    FDA
    13 Sep 2023
    Share Share
    Enforcement Report - Week of March 15, 2023
    Enforcement Report - Week of March 15, 2023

    15 Mar 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-15-2023-86840.pdf

    FDA
    15 Mar 2023
    Share Share
    BAMF's Generic Sodium Fluoride Receives Approval in the U.S.
    BAMF's Generic Sodium Fluoride Receives Approval in the U.S.

    06 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216126

    FDA
    06 Dec 2022
    Share Share